Skip to main content

and
  1. No Access

    Article

    Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma

    We report the case of a 59-year-old man with advanced renal cell carcinoma who developed bilateral papilledema while on therapy with sunitinib, a multi-targeted tyrosine kinase inhibitor (TKI). While papillede...

    Jaclyn Yoong, Geoffrey Chong, K. Hamilton in Medical Oncology (2011)